| Stage | CSTM | % of rev | NMRK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.6B | 100.00% | $888M | 100.00% | CSTM ×2.97 |
| Gross profit | $367M | 13.91% | $349M | 39.25% | NMRK +25.3pp |
| Operating income | $189M | 7.16% | $40M | 4.55% | CSTM +2.6pp |
| Pre-tax income | $160M | 6.06% | $33M | 3.71% | CSTM +2.3pp |
| Net income | $119M | 4.51% | $23M | 2.64% | CSTM +1.9pp |
| Stage | CSTM | NMRK | Gap · A − B |
|---|---|---|---|
| Revenue | $2.6B100.00% | $888M100.00% | CSTM ×2.97 |
| Gross profit | 13.91%$367M | 39.25%$349M | NMRK +25.3pp |
| Operating income | 7.16%$189M | 4.55%$40M | CSTM +2.6pp |
| Pre-tax income | 6.06%$160M | 3.71%$33M | CSTM +2.3pp |
| Net income |
| 4.51%$119M |
| 2.64%$23M |
| CSTM +1.9pp |
None
No disclosed counterparties: CSTM.